HEALTHPEAK PROPERTIES INC

Company Overview

Healthpeak Properties, Inc. is an S&P 500, self-administered healthcare REIT that owns, operates and develops outpatient medical buildings, life-science lab campuses and continuing care retirement communities (CCRCs). Following the March 1, 2024 merger with Physicians Realty Trust the combined portfolio comprises ~697 properties, with lab assets heavily concentrated in San Francisco, San Diego and Boston and most outpatient assets adjacent to hospital campuses. The company emphasizes long-term ownership, triple-net leasing, in‑house property management and selective development to drive durable cash flow and dividend growth, while deploying capital recycling (dispositions/acquisitions) and maintaining an investment‑grade balance sheet.

Executive Compensation Practices

Compensation is likely tied to cash-based operating metrics rather than GAAP net income given the company’s emphasis on Nareit FFO, FFO as Adjusted and AFFO (all materially improved post-merger) and segment Adjusted NOI (outpatient, lab, CCRC). Short‑term incentives for executives will typically reference same‑store NOI growth, leasing spreads/occupancy, development stabilization milestones and FFO/AFFO targets, while long‑term pay is commonly delivered as RSUs/PSUs or performance equity linked to AFFO per share, relative TSR and capital‑efficiency metrics (capex returns, disposition yields). Merger integration and retention awards, one‑time transaction-related payouts, and share repurchase activity (e.g., $188M repurchased in 2024) are also likely drivers; credit‑rating sensitivity, leverage covenants and dividend policy (REIT distribution requirements) will constrain pay design and may include clawbacks and hedging prohibitions.

Insider Trading Considerations

Insider transactions at Healthpeak will often cluster around material corporate events that change cash flow visibility—quarterly FFO/AFFO releases, large dispositions/acquisitions, development stabilization announcements, merger milestones and debt financings—so watch Form 4 filings near those dates. The 2024 merger likely created lockups and retention‑related restrictions; executives frequently use 10b5‑1 plans to schedule trades for REITs with predictable dividend cycles and recurring reporting. Regulatory drivers—Section 16 short‑swing rules, SEC disclosure timing and industry‑specific risks (CMS ownership reporting, tenant reimbursement or fraud/abuse issues)—make timely reporting critical; trades during windows of potential material nonpublic information (tenant credit stress, major lab lease wins/losses, dividend changes) should be treated as higher‑information events.